Introduction Despite international consensus and clearly written guidelines urging wider use
of corticosteroids or combinations of inhaled short-and long-acting β-agonists (SABA and …

Purpose. Both systemic and inhaled corticosteroids may increase the risk of cataract in
patients with both chronic obstructive pulmonary disease (COPD) and asthma. Our aim was …

Background: Oral corticosteroid users are at increased risk of cataract, but the risk among
intranasal corticosteroids users is unknown. Objective: Our purpose was to describe the risk …

Asthma is an inflammatory disease of the airways associated with intermittent episodes of
bronchospasm. Corticosteroids are the most effective anti-inflammatory class of medication …

Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

Inhaled corticosteroids (ICSs) are widely used in the treatment of patients with chronic
obstructive pulmonary diseases. However, high-dose regimens and long-term use of ICSs …

The prevalence of asthma in the most advanced ages is similar to that of younger ages.
However, the concept that older individuals may suffer from allergic asthma has been largely …

Elderly patients with asthma have relatively high rates of hospitalization and mortality.
Although inhaled corticosteroids have been shown to improve outcomes among younger …

Purpose The present study measured 41 soluble mediators in the tear of 19 patients with
age-related cataract and 32 healthy adults as controls. Materials and Methods This was a …

The effectiveness of inhaled corticosteroids (ICS) in patients with chronic obstructive
pulmonary disease (COPD) remains controversial. Randomized controlled trials, meta …